266 related articles for article (PubMed ID: 9808088)
21. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
[TBL] [Abstract][Full Text] [Related]
22. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.
Sassy-Prigent C; Heudes D; Mandet C; Bélair MF; Michel O; Perdereau B; Bariéty J; Bruneval P
Diabetes; 2000 Mar; 49(3):466-75. PubMed ID: 10868970
[TBL] [Abstract][Full Text] [Related]
23. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
[TBL] [Abstract][Full Text] [Related]
27. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
[TBL] [Abstract][Full Text] [Related]
29. Effects of anti-alpha1 integrin subunit antibody on anti-Thy-1 glomerulonephritis.
Kagami S; Urushihara M; Kondo S; Hayashi T; Yamano H; Löster K; Vossmeyer D; Reutter W; Kuroda Y
Lab Invest; 2002 Sep; 82(9):1219-27. PubMed ID: 12218083
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
31. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.
Floege J; Ostendorf T; Janssen U; Burg M; Radeke HH; Vargeese C; Gill SC; Green LS; Janjić N
Am J Pathol; 1999 Jan; 154(1):169-79. PubMed ID: 9916931
[TBL] [Abstract][Full Text] [Related]
32. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.
Johnson RJ; Iida H; Alpers CE; Majesky MW; Schwartz SM; Pritzi P; Gordon K; Gown AM
J Clin Invest; 1991 Mar; 87(3):847-58. PubMed ID: 1671868
[TBL] [Abstract][Full Text] [Related]
33. Post-inflammatory glomerular remodeling is influenced by transformed mesangial cells.
Zhang LS; Aoyagi D; Nakazawa K; Otani M
Pathol Int; 2005 Apr; 55(4):189-201. PubMed ID: 15826245
[TBL] [Abstract][Full Text] [Related]
34. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Urushihara M; Kagami S; Kuhara T; Tamaki T; Kuroda Y
Nephrol Dial Transplant; 2002 Jul; 17(7):1189-96. PubMed ID: 12105240
[TBL] [Abstract][Full Text] [Related]
35. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
Guijarro C; Keane WF
Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
[TBL] [Abstract][Full Text] [Related]
36. Platelet-complement interactions in mesangial proliferative nephritis in the rat.
Johnson RJ; Pritzl P; Iida H; Alpers CE
Am J Pathol; 1991 Feb; 138(2):313-21. PubMed ID: 1704189
[TBL] [Abstract][Full Text] [Related]
37. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
38. Effect of acteoside on mesangial proliferation in rat anti-Thy 1 nephritis.
Hattori T; Fujitsuka N; Shindo S
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):202-12. PubMed ID: 8699610
[TBL] [Abstract][Full Text] [Related]
39. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.
Pichler RH; Bassuk JA; Hugo C; Reed MJ; Eng E; Gordon KL; Pippin J; Alpers CE; Couser WG; Sage EH; Johnson RJ
Am J Pathol; 1996 Apr; 148(4):1153-67. PubMed ID: 8644857
[TBL] [Abstract][Full Text] [Related]
40. Growth factor expression in a murine model of cryoglobulinemia.
Taneda S; Hudkins KL; Cui Y; Farr AG; Alpers CE; Segerer S
Kidney Int; 2003 Feb; 63(2):576-90. PubMed ID: 12631122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
